Detalles de la búsqueda
1.
Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune Adjuvant.
J Virol
; 95(2)2020 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33115866
2.
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
J Virol
; 93(3)2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30429340
3.
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
J Virol
; 93(3)2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30429343
4.
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates.
J Virol
; 92(8)2018 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29437967
5.
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
J Virol
; 91(9)2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28179536
6.
NFκB activation by modified vaccinia virus as a novel strategy to enhance neutrophil migration and HIV-specific T-cell responses.
Proc Natl Acad Sci U S A
; 112(11): E1333-42, 2015 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25739961
7.
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
J Virol
; 90(8): 4133-4149, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26865719
8.
Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.
J Virol
; 89(7): 3819-32, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25609807
9.
Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
J Virol
; 89(2): 970-88, 2015 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25355891
10.
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.
J Virol
; 89(16): 8525-39, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26041302
11.
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.
J Virol
; 89(12): 6462-80, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25855741
12.
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.
J Antimicrob Chemother
; 70(6): 1833-42, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25724985
13.
Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC".
J Virol
; 93(21)2019 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31615930
14.
Involvement of the cellular phosphatase DUSP1 in vaccinia virus infection.
PLoS Pathog
; 9(11): e1003719, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24244156
15.
High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome.
J Virol
; 87(13): 7282-300, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23596307
16.
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.
Proc Natl Acad Sci U S A
; 108(17): 7131-6, 2011 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21467219
17.
Unveiling the Multifaceted Roles of ISG15: From Immunomodulation to Therapeutic Frontiers.
Vaccines (Basel)
; 12(2)2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38400136
18.
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium.
NPJ Vaccines
; 9(1): 53, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38448450
19.
New vaccinia virus promoter as a potential candidate for future vaccines.
J Gen Virol
; 94(Pt 12): 2771-2776, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24077296
20.
Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice.
J Virol
; 86(9): 5026-38, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22419805